Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer
- 1 December 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 35 (3) , 323-329
- https://doi.org/10.1016/0090-8258(89)90072-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- CA 125 serum levels correlate with second-look operations among ovarian cancer patients: A prospective multi-institutional studyGynecologic Oncology, 1986
- CA 125 surveillance and second-look laparotomy in ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervixAmerican Journal of Obstetrics and Gynecology, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983
- Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell TypesAmerican Journal of Clinical Pathology, 1983
- Second-look laparotomy in the management of gynecologic malignancyGynecologic Oncology, 1982
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Differential Diagnosis of Pleural EffusionsChest, 1981
- Diagnostic Value of Carcinoembryonic Antigen in Exudative Pleural EffusionsChest, 1980